<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>CurrentAnesthesia — Obstetric anesthesia</title>
<subtitle>The newest Briefs placed in Obstetric anesthesia.</subtitle>
<id>https://currentanesthesia.com/topics/obstetric-anesthesia/feed.xml</id>
<link rel="self" type="application/atom+xml" href="https://currentanesthesia.com/topics/obstetric-anesthesia/feed.xml"/>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/topics/obstetric-anesthesia/"/>
<updated>2026-10-28T04:40:50.491Z</updated>
<author><name>CurrentAnesthesia</name><uri>https://currentanesthesia.com/topics/obstetric-anesthesia/</uri></author>
<entry>
<title>Ventilatory Parameters in Obstetric Patients With COVID-19 and Impact of Delivery: A Multicenter Prospective Cohort Study</title>
<id>https://currentanesthesia.com/studies/ventilatory-parameters-in-obstetric-patients-with-covid-19-and-impact-of-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/ventilatory-parameters-in-obstetric-patients-with-covid-19-and-impact-of-2022/"/>
<published>2026-10-28T04:40:50.491Z</published>
<updated>2026-10-28T04:40:50.491Z</updated>
<summary>Cohort study · Chest, 2022. Respiratory parameters before and after delivery: Before delivery mean 25.6 ± 6.6 cm H2O; plateau pressure 25.6 ± 6.6 cm H2O; driving pressure 13.6 ± 4.2 cm H2O; median static compliance 28 mL/cm H2O (IQR, 22.5-39); PaO2/FiO2 134 (IQR, 100-230) · After delivery ≤ 2 h mean 24 ± 6.7 cm H2O; plateau pressure 24 ± 6.7 cm H2O; driving pressure 12.9 ± 3.9 cm H2O; median static compliance 30 mL/cm H2O (IQR, 24.5-44); PaO2/FiO2 168 (IQR, 136-185) · After delivery 24 h mean 24.6 ± 5.2 cm H2O; plateau pressure 24.6 ± 5.2 cm H2O; driving pressure 13 ± 4.4 cm H2O; median static compliance 30 mL/cm H2O (IQR, 24.5-44); PaO2/FiO2 192 (IQR, 132-232.5)</summary>
</entry>
<entry>
<title>Outcome predictors and patient progress following delivery in pregnant and postpartum patients with severe COVID-19 pneumonitis in intensive care units in Israel (OB-COVICU): a nationwide cohort study</title>
<id>https://currentanesthesia.com/studies/outcome-predictors-patient-progress-following-delivery-pregnant-postpartum-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/outcome-predictors-patient-progress-following-delivery-pregnant-postpartum-2023/"/>
<published>2026-10-28T04:39:17.656Z</published>
<updated>2026-10-28T04:39:17.656Z</updated>
<summary>Cohort study · Lancet Respir Med, 2023. Maternal outcome: IPPV (events), ECMO and death (measures): delivery-critical 26 (81%); ECMO 12 (38%); Death 1 (3%) · postpartum 4 (100%); ECMO 3 (75%); Death 2 (50%) · no-delivery 6 (18%); ECMO 0; Death 0 · delivery-non-critical 2 (14%); ECMO 0; Death 0</summary>
</entry>
<entry>
<title>Comparison between the Rotational Thromboelastometry (ROTEM) Delta device against the Cartridge-based Thromboelastography 6s and Quantra in a healthy third trimester pregnant cohort</title>
<id>https://currentanesthesia.com/studies/comparison-between-rotational-thromboelastometry-rotem-delta-device-against-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/comparison-between-rotational-thromboelastometry-rotem-delta-device-against-2022/"/>
<published>2026-10-28T04:08:44.882Z</published>
<updated>2026-10-28T04:08:44.882Z</updated>
<summary>Research article · J Clin Monit Comput, 2022. Correlation with Clauss fibrinogen: ROTEM r 0.76-0.84; P P &lt; 0.0001 · TEG6s r 0.71; P P &lt; 0.0001 · Quantra r 0.72; P P = 0.0001</summary>
</entry>
<entry>
<title>Challenges and pitfalls of extracorporeal membrane oxygenation in critically-ill pregnant and peripartum women with COVID-19: a retrospective case series</title>
<id>https://currentanesthesia.com/studies/challenges-pitfalls-extracorporeal-membrane-oxygenation-critically-ill-pregnant-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/challenges-pitfalls-extracorporeal-membrane-oxygenation-critically-ill-pregnant-2023/"/>
<published>2026-10-28T04:06:59.719Z</published>
<updated>2026-10-28T04:06:59.719Z</updated>
<summary>Cohort study · Int J Obstet Anesth, 2023. Maternal and neonatal outcomes: Newborns surviving to hospital discharge 4 of 5</summary>
</entry>
<entry>
<title>Clinical and ultrasonographic assessment of airway indices among non-pregnant, normotensive pregnant and pre-eclamptic patients: a prospective observational study</title>
<id>https://currentanesthesia.com/studies/clinical-and-ultrasonographic-assessment-of-airway-indices-among-non-pregnant-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/clinical-and-ultrasonographic-assessment-of-airway-indices-among-non-pregnant-2023/"/>
<published>2026-10-28T04:06:59.719Z</published>
<updated>2026-10-28T04:06:59.719Z</updated>
<summary>Cohort study · Int J Obstet Anesth, 2023. Clinical and sonographic airway indices: Several significant differences between pregnant and non-pregnant females, with additional changes in pre-eclamptic females: modified Mallampati score; sonographic tongue width, tongue volume, subglottic diameter, anterior neck soft tissue thickness at hyoid, epiglottis and vocal cords, and ratio of pre-epiglottic space to anterior, posterior and midpoint of anterior and posterior vocal folds</summary>
</entry>
<entry>
<title>Comparative efficacy of quadratus lumborum type-II and erector spinae plane block in patients undergoing caesarean section under spinal anaesthesia: a randomised controlled trial</title>
<id>https://currentanesthesia.com/studies/comparative-efficacy-quadratus-lumborum-type-ii-erector-spinae-plane-block-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/comparative-efficacy-quadratus-lumborum-type-ii-erector-spinae-plane-block-2022/"/>
<published>2026-10-28T04:06:59.719Z</published>
<updated>2026-10-28T04:06:59.719Z</updated>
<summary>Randomized controlled trial · Int J Obstet Anesth, 2022. Cumulative number of fentanyl doses, 24-h postoperative period: No significant difference in cumulative number of fentanyl doses between QLB-II and ESPB (W = 349.000) P = 0.840</summary>
</entry>
<entry>
<title>COVID-19 infection and maternal morbidity in critical care units in Scotland: a national cohort study</title>
<id>https://currentanesthesia.com/studies/covid-19-infection-and-maternal-morbidity-in-critical-care-units-in-scotland-a-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/covid-19-infection-and-maternal-morbidity-in-critical-care-units-in-scotland-a-2022/"/>
<published>2026-10-28T04:06:59.719Z</published>
<updated>2026-10-28T04:06:59.719Z</updated>
<summary>Cohort study · Int J Obstet Anesth, 2022. Hospital outcomes and re-admission: From the most deprived socio-economic areas 49 (65%)</summary>
</entry>
<entry>
<title>Evaluation of ultrasound airway assessment parameters in pregnant patients and their comparison with that of non-pregnant women: a prospective cohort study</title>
<id>https://currentanesthesia.com/studies/evaluation-ultrasound-airway-assessment-parameters-pregnant-their-comparison-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/evaluation-ultrasound-airway-assessment-parameters-pregnant-their-comparison-2022/"/>
<published>2026-10-28T04:06:59.719Z</published>
<updated>2026-10-28T04:06:59.719Z</updated>
<summary>Cohort study · Int J Obstet Anesth, 2022. US airway parameters: Significantly higher hyomental distance, anterior neck soft tissue thickness at hyoid and vocal cord level, and oral cavity height in pregnant patients</summary>
</entry>
<entry>
<title>Fetal outcomes with and without the use of sugammadex in pregnant patients undergoing non-obstetric surgery: a multicenter retrospective study</title>
<id>https://currentanesthesia.com/studies/fetal-outcomes-with-and-without-the-use-of-sugammadex-in-pregnant-patients-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/fetal-outcomes-with-and-without-the-use-of-sugammadex-in-pregnant-patients-2022/"/>
<published>2026-10-28T04:06:59.719Z</published>
<updated>2026-10-28T04:06:59.719Z</updated>
<summary>Cohort study · Int J Obstet Anesth, 2022. Miscarriage or preterm birth, within four weeks after surgery: GA with SGX 3.0 % · GA without SGX 4.3 %</summary>
</entry>
<entry>
<title>Hemodynamic changes in patients with SARS-CoV-2 infection presenting for cesarean delivery under spinal anesthesia: a retrospective case-control study</title>
<id>https://currentanesthesia.com/studies/hemodynamic-changes-in-patients-with-sars-cov-2-infection-presenting-for-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/hemodynamic-changes-in-patients-with-sars-cov-2-infection-presenting-for-2022/"/>
<published>2026-10-28T04:06:59.719Z</published>
<updated>2026-10-28T04:06:59.719Z</updated>
<summary>Case-control study · Int J Obstet Anesth, 2022. Post-spinal MAP — SARS-CoV-2 positive vs Controls: difference 5.6 mmHg; higher, on average, adjusted for covariates</summary>
</entry>
<entry>
<title>Maternal heart rate variability patterns associated with maternal hypotension and non-reassuring fetal heart rate patterns following initiation of combined spinal-epidural labor analgesia: a prospective observational trial</title>
<id>https://currentanesthesia.com/studies/maternal-heart-rate-variability-patterns-associated-maternal-hypotension-non-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/maternal-heart-rate-variability-patterns-associated-maternal-hypotension-non-2023/"/>
<published>2026-10-28T04:06:59.719Z</published>
<updated>2026-10-28T04:06:59.719Z</updated>
<summary>Cohort study · Int J Obstet Anesth, 2023. Prediction of maternal hypotension (AUC of baseline measures): Baseline low-frequency (LF)/high-frequency (HF) ratio: AUC 0.677 (95% CI 0.55 to 0.80) · ANI: AUC 0.858 (95% CI 0.78 to 0.94)</summary>
</entry>
<entry>
<title>Persistent opioid use after cesarean delivery in the United States of America: a systematic review</title>
<id>https://currentanesthesia.com/studies/persistent-opioid-use-after-cesarean-delivery-in-the-united-states-of-america-a-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/persistent-opioid-use-after-cesarean-delivery-in-the-united-states-of-america-a-2023/"/>
<published>2026-10-28T04:06:59.719Z</published>
<updated>2026-10-28T04:06:59.719Z</updated>
<summary>Meta-analysis · Int J Obstet Anesth, 2023. Rate of persistent opioid use after cesarean delivery, up to 12 months postpartum: Range of rates across studies 0.12% to 2.2%</summary>
</entry>
<entry>
<title>The use of epinephrine infusion for the prevention of spinal hypotension during Caesarean delivery: A randomized controlled dose-finding trial</title>
<id>https://currentanesthesia.com/studies/the-use-of-epinephrine-infusion-for-the-prevention-of-spinal-hypotension-during-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/the-use-of-epinephrine-infusion-for-the-prevention-of-spinal-hypotension-during-2023/"/>
<published>2026-10-28T03:54:35.559Z</published>
<updated>2026-10-28T03:54:35.559Z</updated>
<summary>Randomized controlled trial · Anaesth Crit Care Pain Med, 2023. Spinal hypotension: 0.01 mcg 55 (61%) · 0.02 mcg 32 (35%) · 0.03 mcg 11 (12%)</summary>
</entry>
<entry>
<title>Anesthetic management of patients with class 3 obesity undergoing elective Cesarean delivery: a single-centre historical cohort study</title>
<id>https://currentanesthesia.com/studies/anesthetic-management-of-patients-with-class-3-obesity-undergoing-elective-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/anesthetic-management-of-patients-with-class-3-obesity-undergoing-elective-2022/"/>
<published>2026-10-28T03:51:30.684Z</published>
<updated>2026-10-28T03:51:30.684Z</updated>
<summary>Cohort study · Can J Anaesth, 2022. Spinal anesthesia as anesthetic technique of first choice: BMI 40.0-49.9 kg·m-2 71%</summary>
</entry>
<entry>
<title>Comparison of different delivery modalities of epidural analgesia and intravenous analgesia in labour: a systematic review and network meta-analysis</title>
<id>https://currentanesthesia.com/studies/comparison-different-delivery-modalities-epidural-analgesia-intravenous-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/comparison-different-delivery-modalities-epidural-analgesia-intravenous-2023/"/>
<published>2026-10-28T03:51:30.684Z</published>
<updated>2026-10-28T03:51:30.684Z</updated>
<summary>Meta-analysis · Can J Anaesth, 2023. Need for rescue analgesia; maternal satisfaction (coprimary): Rescue analgesia: CEI inferior to PIEB; PIEB + PCEA superior to PCEA alone (low certainty of evidence)</summary>
</entry>
<entry>
<title>Incidence of bradycardia during noradrenaline or phenylephrine bolus treatment of postspinal hypotension in cesarean delivery: A randomized double‐blinded controlled trial</title>
<id>https://currentanesthesia.com/studies/incidence-bradycardia-during-noradrenaline-or-phenylephrine-bolus-treatment-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/incidence-bradycardia-during-noradrenaline-or-phenylephrine-bolus-treatment-2023/"/>
<published>2026-10-28T03:44:37.230Z</published>
<updated>2026-10-28T03:44:37.230Z</updated>
<summary>Randomized controlled trial · Acta Anaesthesiol Scand, 2023. Bradycardia incidence (&lt;60 bpm) with intermittent bolus administration: Noradrenaline 51.4% · Phenylephrine 70.3%</summary>
</entry>
<entry>
<title>Incidence of conversion to general anaesthesia and need for intravenous supplementation in parturients undergoing caesarean section under spinal anaesthesia: A retrospective observational study</title>
<id>https://currentanesthesia.com/studies/incidence-conversion-general-anaesthesia-need-intravenous-supplementation-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/incidence-conversion-general-anaesthesia-need-intravenous-supplementation-2022/"/>
<published>2026-10-28T03:44:37.230Z</published>
<updated>2026-10-28T03:44:37.230Z</updated>
<summary>Cohort study · Acta Anaesthesiol Scand, 2022. Conversion to GA: Women requiring conversion to GA 1.7%</summary>
</entry>
<entry>
<title>Comparison of labor analgesia efficacy between single-orifice and multiorifice wire-reinforced catheters during programmed intermittent epidural boluses: a randomized controlled clinical trial</title>
<id>https://currentanesthesia.com/studies/comparison-labor-analgesia-efficacy-between-single-orifice-multiorifice-wire-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/comparison-labor-analgesia-efficacy-between-single-orifice-multiorifice-wire-2022/"/>
<published>2026-10-28T03:38:31.027Z</published>
<updated>2026-10-28T03:38:31.027Z</updated>
<summary>Randomized controlled trial · Reg Anesth Pain Med, 2022. Adequate analgesia, 20 min: Single-orifice 71.8% · Multiorifice 56.0%</summary>
</entry>
<entry>
<title>The comparison of caesarean section bleeding between volatile and total intravenous anaesthesia in a Japanese nationwide database</title>
<id>https://currentanesthesia.com/studies/the-comparison-of-caesarean-section-bleeding-between-volatile-and-total-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/the-comparison-of-caesarean-section-bleeding-between-volatile-and-total-2023/"/>
<published>2026-10-28T03:38:06.189Z</published>
<updated>2026-10-28T03:38:06.189Z</updated>
<summary>Cohort study · Eur J Anaesthesiol Intensive Care, 2023. Blood loss: Volatile mean 1113 ± 909 ml · TIVA mean 1136 ± 944 ml</summary>
</entry>
<entry>
<title>Incidence of Interstitial Alveolar Syndrome on Point-of-Care Lung Ultrasonography in Pre-eclamptic Women With Severe Features: A Prospective Observational Study</title>
<id>https://currentanesthesia.com/studies/incidence-interstitial-alveolar-syndrome-point-care-lung-ultrasonography-pre-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/incidence-interstitial-alveolar-syndrome-point-care-lung-ultrasonography-pre-2023/"/>
<published>2026-10-28T03:28:59.708Z</published>
<updated>2026-10-28T03:28:59.708Z</updated>
<summary>Cohort study · Anesth Analg, 2023. B-lines on LUS: B-lines at admission (45/70 vs 25/70 without B-lines; P = .02) 64.3%</summary>
</entry>
<entry>
<title>Labor Neuraxial Analgesia and Its Association With Perinatal Outcomes in China in 2015–2016: A Propensity Score–Matched Analysis</title>
<id>https://currentanesthesia.com/studies/labor-neuraxial-analgesia-and-its-association-with-perinatal-outcomes-in-china-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/labor-neuraxial-analgesia-and-its-association-with-perinatal-outcomes-in-china-2023/"/>
<published>2026-10-28T03:28:59.708Z</published>
<updated>2026-10-28T03:28:59.708Z</updated>
<summary>Cross-sectional study · Anesth Analg, 2023. Weighted NA rate: NA 17.3% (CI 95% 16.6-18.0)</summary>
</entry>
<entry>
<title>Manually Controlled, Continuous Infusion of Phenylephrine or Norepinephrine for Maintenance of Blood Pressure and Cardiac Output During Spinal Anesthesia for Cesarean Delivery: A Double-Blinded Randomized Study</title>
<id>https://currentanesthesia.com/studies/manually-controlled-continuous-infusion-phenylephrine-or-norepinephrine-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/manually-controlled-continuous-infusion-phenylephrine-or-norepinephrine-2022/"/>
<published>2026-10-28T03:28:59.708Z</published>
<updated>2026-10-28T03:28:59.708Z</updated>
<summary>Randomized controlled trial · Anesth Analg, 2022. Cardiac index (% of baseline), from SA to umbilical cord clamping: Norepinephrine 90% and 100% % of baseline · Phenylephrine 81%-88% % of baseline</summary>
</entry>
<entry>
<title>Opioid-Sparing Multimodal Analgesia Use After Cesarean Delivery Under General Anesthesia: A Retrospective Cohort Study in 729 US Hospitals</title>
<id>https://currentanesthesia.com/studies/opioid-sparing-multimodal-analgesia-use-after-cesarean-delivery-under-general-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/opioid-sparing-multimodal-analgesia-use-after-cesarean-delivery-under-general-2023/"/>
<published>2026-10-28T03:28:59.708Z</published>
<updated>2026-10-28T03:28:59.708Z</updated>
<summary>Cohort study · Anesth Analg, 2023. osMMA use: osMMA used, n (%) 11,133 (8.5%)</summary>
</entry>
<entry>
<title>Postcesarean Analgesia With Epidural Morphine After Epidural 2-Chloroprocaine: A Randomized Noninferiority Trial</title>
<id>https://currentanesthesia.com/studies/postcesarean-analgesia-with-epidural-morphine-after-epidural-2-chloroprocaine-a-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/postcesarean-analgesia-with-epidural-morphine-after-epidural-2-chloroprocaine-a-2022/"/>
<published>2026-10-28T03:28:59.708Z</published>
<updated>2026-10-28T03:28:59.708Z</updated>
<summary>Randomized controlled trial · Anesth Analg, 2022. Total opioid consumption in first 24 h after epidural morphine (oral MME), 24 hours: CP median 0 (Q1–Q3 Q1 = 0 and Q3 = 15.6) oral milligram morphine equivalents · LEB median 15 (Q1–Q3 6.3-22.5) oral milligram morphine equivalents</summary>
</entry>
<entry>
<title>Preventing Spinal Hypotension During Cesarean Birth With Two Initial Boluses of Norepinephrine in Chinese Parturients: A Randomized, Double-Blind, Controlled Trial</title>
<id>https://currentanesthesia.com/studies/preventing-spinal-hypotension-during-cesarean-birth-with-two-initial-boluses-of-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/preventing-spinal-hypotension-during-cesarean-birth-with-two-initial-boluses-of-2022/"/>
<published>2026-10-28T03:28:59.708Z</published>
<updated>2026-10-28T03:28:59.708Z</updated>
<summary>Randomized controlled trial · Anesth Analg, 2022. Frequency of spinal hypotension during cesarean birth: 0.10 μg/kg 20.7% · 0.05 μg/kg 45.6%</summary>
</entry>
<entry>
<title>Randomized Assessment of the Optimal Time Interval Between Programmed Intermittent Epidural Boluses When Combined With the Dural Puncture Epidural Technique for Labor Analgesia</title>
<id>https://currentanesthesia.com/studies/randomized-assessment-optimal-time-interval-between-programmed-intermittent-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/randomized-assessment-optimal-time-interval-between-programmed-intermittent-2022/"/>
<published>2026-10-28T03:28:59.708Z</published>
<updated>2026-10-28T03:28:59.708Z</updated>
<summary>Randomized controlled trial · Anesth Analg, 2022. Effective PIEB analgesia, first stage of labor: 35 17 (89.5%) · 40 16 (84.2%) · 45 14 (82.4%) · 50 11 (52.6%) · 55 7 (36.8%)</summary>
</entry>
<entry>
<title>Ultrasound Assessment of Gastric Volume in Parturients After High-Flow Nasal Oxygen Therapy</title>
<id>https://currentanesthesia.com/studies/ultrasound-assessment-of-gastric-volume-in-parturients-after-high-flow-nasal-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/ultrasound-assessment-of-gastric-volume-in-parturients-after-high-flow-nasal-2023/"/>
<published>2026-10-28T03:28:59.708Z</published>
<updated>2026-10-28T03:28:59.708Z</updated>
<summary>Cohort study · Anesth Analg, 2023. Estimated gastric fluid volume (semirecumbent right lateral position): Baseline 38.51 (range or interval as printed 33.39-54.62) mL · After HFNO 39.71 (range or interval as printed 32.00-52.82) mL</summary>
</entry>
<entry>
<title>A national cohort study to investigate the association between ethnicity and the provision of care in obstetric anaesthesia in England between 2011 and 2021</title>
<id>https://currentanesthesia.com/studies/a-national-cohort-study-to-investigate-the-association-between-ethnicity-and-the-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/a-national-cohort-study-to-investigate-the-association-between-ethnicity-and-the-2023/"/>
<published>2026-10-28T03:25:23.999Z</published>
<updated>2026-10-28T03:25:23.999Z</updated>
<summary>Cohort study · Anaesthesia, 2023. GA, elective caesarean births — Caribbean (black or black British) vs British (white): adjusted incidence ratio 1.58 (95% CI 1.26-1.97); 58% more common</summary>
</entry>
<entry>
<title>Associations between postpartum pain type, pain intensity and opioid use in patients with and without opioid use disorder: a cross-sectional study</title>
<id>https://currentanesthesia.com/studies/associations-between-postpartum-pain-type-pain-intensity-and-opioid-use-in-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/associations-between-postpartum-pain-type-pain-intensity-and-opioid-use-in-2022/"/>
<published>2026-10-28T03:18:44.786Z</published>
<updated>2026-10-28T03:18:44.786Z</updated>
<summary>Cross-sectional study · Br J Anaesth, 2022. Pain intensity and total oxycodone by pain type: Pain types associated with pain intensity P&lt;0.001</summary>
</entry>
<entry>
<title>Thromboelastometry-guided treatment algorithm in postpartum haemorrhage: a randomised, controlled pilot trial</title>
<id>https://currentanesthesia.com/studies/thromboelastometry-guided-treatment-algorithm-in-postpartum-haemorrhage-a-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/thromboelastometry-guided-treatment-algorithm-in-postpartum-haemorrhage-a-2022/"/>
<published>2026-10-28T03:18:44.786Z</published>
<updated>2026-10-28T03:18:44.786Z</updated>
<summary>Randomized controlled trial · Br J Anaesth, 2022. RBC units transfused: ROTEM median 2 (IQR 1-4) units · Control median 3 (IQR 2-4) units</summary>
</entry>
<entry>
<title>Outcomes Following Extracorporeal Membrane Oxygenation for Severe COVID-19 in Pregnancy or Post Partum</title>
<id>https://currentanesthesia.com/studies/outcomes-following-extracorporeal-membrane-oxygenation-for-severe-covid-19-in-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/outcomes-following-extracorporeal-membrane-oxygenation-for-severe-covid-19-in-2023/"/>
<published>2026-10-27T23:37:19.358Z</published>
<updated>2026-10-27T23:37:19.358Z</updated>
<summary>Cohort study · JAMA Netw Open, 2023. Maternal mortality: Maternal deaths, whole cohort: 16 16.0% (16.0%; 95% CI 8.2%-23.8%)</summary>
</entry>
<entry>
<title>Randomized Trial of Early Detection and Treatment of Postpartum Hemorrhage</title>
<id>https://currentanesthesia.com/studies/randomized-trial-of-early-detection-and-treatment-of-postpartum-hemorrhage-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/randomized-trial-of-early-detection-and-treatment-of-postpartum-hemorrhage-2023/"/>
<published>2026-10-27T23:35:39.811Z</published>
<updated>2026-10-27T23:35:39.811Z</updated>
<summary>Randomized controlled trial · N Engl J Med, 2023. Composite of severe PPH (blood loss ≥1000 ml), laparotomy for bleeding, or maternal death from bleeding: Intervention 1.6% · Usual care 4.3%</summary>
</entry>
<entry>
<title>Tranexamic Acid to Prevent Obstetrical Hemorrhage after Cesarean Delivery</title>
<id>https://currentanesthesia.com/studies/tranexamic-acid-to-prevent-obstetrical-hemorrhage-after-cesarean-delivery-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/tranexamic-acid-to-prevent-obstetrical-hemorrhage-after-cesarean-delivery-2023/"/>
<published>2026-10-27T23:35:39.811Z</published>
<updated>2026-10-27T23:35:39.811Z</updated>
<summary>Randomized controlled trial · N Engl J Med, 2023. Composite of maternal death or blood transfusion, by hospital discharge or 7 days post partum, whichever came first: Tranexamic acid 201 (3.6%) · Placebo 233 (4.3%)</summary>
</entry>
<entry>
<title>Evaluation of intravenous infusion of labetalol versus magnesium sulfate on cerebral hemodynamics of preeclampsia patients with severe features using transcranial doppler</title>
<id>https://currentanesthesia.com/studies/evaluation-intravenous-infusion-labetalol-magnesium-sulfate-cerebral-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/evaluation-intravenous-infusion-labetalol-magnesium-sulfate-cerebral-2023/"/>
<published>2026-10-27T23:08:04.173Z</published>
<updated>2026-10-27T23:08:04.173Z</updated>
<summary>Randomized controlled trial · J Clin Monit Comput, 2023. Cerebral hemodynamics by TCD: MCA mean flow velocity, mean end-diastolic velocity, pulsatility index (PI), estimated CPP, 1 and 6 hours after administration: group M: PI 0.77 ± 0.04 at baseline vs 0.66 ± 0.05 at 1 h and 0.66 ± 0.05 at 6 h (p value &lt; 0.001)</summary>
</entry>
<entry>
<title>A survey in the West Midlands of the United Kingdom of current practice in managing hypotension in lower segment caesarean section under spinal anaesthesia</title>
<id>https://currentanesthesia.com/studies/a-survey-in-the-west-midlands-of-the-united-kingdom-of-current-practice-in-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/a-survey-in-the-west-midlands-of-the-united-kingdom-of-current-practice-in-2023/"/>
<published>2026-10-27T23:06:15.669Z</published>
<updated>2026-10-27T23:06:15.669Z</updated>
<summary>Cross-sectional study · Int J Obstet Anesth, 2023. Adherence to 2017 international consensus recommendations on managing hypotension during caesarean section under spinal anaesthesia; local guidelines; clinicians' treatment thresholds: Sites with a policy for vasopressor use 73%</summary>
</entry>
<entry>
<title>Global obstetric anaesthesia: bridging the gap in maternal health care inequities through partnership in education</title>
<id>https://currentanesthesia.com/studies/global-obstetric-anaesthesia-bridging-the-gap-in-maternal-health-care-inequities-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/global-obstetric-anaesthesia-bridging-the-gap-in-maternal-health-care-inequities-2023/"/>
<published>2026-10-27T23:06:15.669Z</published>
<updated>2026-10-27T23:06:15.669Z</updated>
<summary>Research article · Int J Obstet Anesth, 2023. LMICs face inadequate anaesthesia workforce, under-resourced health systems and sub-optimal access to labour and delivery care, negatively impacting maternal and neonatal outcomes</summary>
</entry>
<entry>
<title>Improving blood product management in placenta accreta patients with severe bleeding: institutional experience</title>
<id>https://currentanesthesia.com/studies/improving-blood-product-management-in-placenta-accreta-patients-with-severe-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/improving-blood-product-management-in-placenta-accreta-patients-with-severe-2023/"/>
<published>2026-10-27T23:06:15.669Z</published>
<updated>2026-10-27T23:06:15.669Z</updated>
<summary>Cohort study · Int J Obstet Anesth, 2023. Peri-operative outcomes: Deaths 0</summary>
</entry>
<entry>
<title>Inadequate neuraxial anaesthesia during caesarean delivery: a survey of practitioners</title>
<id>https://currentanesthesia.com/studies/inadequate-neuraxial-anaesthesia-during-caesarean-delivery-a-survey-of-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/inadequate-neuraxial-anaesthesia-during-caesarean-delivery-a-survey-of-2023/"/>
<published>2026-10-27T23:06:15.669Z</published>
<updated>2026-10-27T23:06:15.669Z</updated>
<summary>Cross-sectional study · Int J Obstet Anesth, 2023. Knowledge, training, practices and attitudes regarding failed neuraxial anaesthesia for caesarean delivery: Routinely inform patients of difference between pain and expected intra-operative sensations 320/327, 97.9%</summary>
</entry>
<entry>
<title>The effects of intrathecal morphine on urinary bladder function and recovery in patients having a cesarean delivery – A randomized clinical trial</title>
<id>https://currentanesthesia.com/studies/the-effects-of-intrathecal-morphine-on-urinary-bladder-function-and-recovery-in-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/the-effects-of-intrathecal-morphine-on-urinary-bladder-function-and-recovery-in-2023/"/>
<published>2026-10-27T22:55:35.298Z</published>
<updated>2026-10-27T22:55:35.298Z</updated>
<summary>Randomized controlled trial · Anaesth Crit Care Pain Med, 2023. Time to first micturition: PSM 10 (range 8-12) hours · PS 6 (range 6-8) hours</summary>
</entry>
<entry>
<title>Effect of an oxytocin protocol on secondary uterotonic use in patients undergoing Cesarean delivery</title>
<id>https://currentanesthesia.com/studies/effect-of-an-oxytocin-protocol-on-secondary-uterotonic-use-in-patients-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/effect-of-an-oxytocin-protocol-on-secondary-uterotonic-use-in-patients-2023/"/>
<published>2026-10-27T22:52:26.060Z</published>
<updated>2026-10-27T22:52:26.060Z</updated>
<summary>Cohort study · Can J Anaesth, 2023. Secondary uterotonic use — Postprotocol vs Preprotocol: OR 1.33 (95% CI 1.04 to 1.70); P = 0.02</summary>
</entry>
<entry>
<title>Racial and ethnic disparities in obstetric anesthesia: a scoping review</title>
<id>https://currentanesthesia.com/studies/racial-and-ethnic-disparities-in-obstetric-anesthesia-a-scoping-review-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/racial-and-ethnic-disparities-in-obstetric-anesthesia-a-scoping-review-2023/"/>
<published>2026-10-27T22:52:26.060Z</published>
<updated>2026-10-27T22:52:26.060Z</updated>
<summary>Research article · Can J Anaesth, 2023. Racial and ethnic disparities in obstetric anesthesia (peripartum, USA): Disparities described in use of labour epidural analgesia, labour epidural request timing, anesthesia for Cesarean deliveries, postpartum pain management, and epidural blood patch for PDPH</summary>
</entry>
<entry>
<title>Labour analgesia by single shot spinal for any parturient?—A retrospective one‐year single centre audit</title>
<id>https://currentanesthesia.com/studies/labour-analgesia-by-single-shot-spinal-for-any-parturient-a-retrospective-one-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/labour-analgesia-by-single-shot-spinal-for-any-parturient-a-retrospective-one-2023/"/>
<published>2026-10-27T22:48:29.585Z</published>
<updated>2026-10-27T22:48:29.585Z</updated>
<summary>Cohort study · Acta Anaesthesiol Scand, 2023. Insufficient duration of analgesia — Primiparous vs Advanced multiparous: OR 1.94 (CI 1.08-3.48); p &lt; .01</summary>
</entry>
<entry>
<title>Pre‐oxygenation using high‐flow nasal oxygen in parturients undergoing caesarean section in general anaesthesia: A prospective, multi‐centre, pilot study</title>
<id>https://currentanesthesia.com/studies/pre-oxygenation-using-high-flow-nasal-oxygen-in-parturients-undergoing-caesarean-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/pre-oxygenation-using-high-flow-nasal-oxygen-in-parturients-undergoing-caesarean-2023/"/>
<published>2026-10-27T22:48:29.585Z</published>
<updated>2026-10-27T22:48:29.585Z</updated>
<summary>Cohort study · Acta Anaesthesiol Scand, 2023. Proportion desaturating below 93%, from start of pre-oxygenation until 1 min after tracheal intubation: HFNO 0 · Facemask 0</summary>
</entry>
<entry>
<title>Association between maternal labour epidural analgesia and autistic traits in offspring</title>
<id>https://currentanesthesia.com/studies/association-between-maternal-labour-epidural-analgesia-and-autistic-traits-in-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/association-between-maternal-labour-epidural-analgesia-and-autistic-traits-in-2023/"/>
<published>2026-10-27T22:44:42.780Z</published>
<updated>2026-10-27T22:44:42.780Z</updated>
<summary>Cohort study · J Clin Anesth, 2023. Abnormal Social Responsiveness Scale (SRS) T score (≥60 points), 7 years: MEA 19.9% · Non-exposed 26.1%</summary>
</entry>
<entry>
<title>Determination of the Optimal Volume of Programmed Intermittent Epidural Bolus When Combined With the Dural Puncture Epidural Technique for Labor Analgesia: A Random-Allocation Graded Dose-Response Study</title>
<id>https://currentanesthesia.com/studies/determination-optimal-volume-programmed-intermittent-epidural-bolus-when-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/determination-optimal-volume-programmed-intermittent-epidural-bolus-when-2023/"/>
<published>2026-10-27T22:35:32.011Z</published>
<updated>2026-10-27T22:35:32.011Z</updated>
<summary>Randomized controlled trial · Anesth Analg, 2023. Effective labor analgesia: 6 mL 32% · 8 mL 64% · 10 mL 76% · 12 mL 96%</summary>
</entry>
<entry>
<title>General Anesthesia for Cesarean Delivery for Thrombocytopenia in Hypertensive Disorders of Pregnancy: Findings From the Obstetric Airway Management Registry</title>
<id>https://currentanesthesia.com/studies/general-anesthesia-cesarean-delivery-thrombocytopenia-hypertensive-disorders-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/general-anesthesia-cesarean-delivery-thrombocytopenia-hypertensive-disorders-2022/"/>
<published>2026-10-27T22:35:32.011Z</published>
<updated>2026-10-27T22:35:32.011Z</updated>
<summary>Cohort study · Anesth Analg, 2022. Thrombocytopenia as indication for GA: Confirmed thrombocytopenia 48 (8.1%) · Suspected thrombocytopenia 52 (8.8%)</summary>
</entry>
<entry>
<title>The Incidence and Predictors of Failed Spinal Anesthesia After Intrathecal Injection of Local Anesthetic for Cesarean Delivery: A Single-Center, 9-Year Retrospective Review</title>
<id>https://currentanesthesia.com/studies/incidence-predictors-failed-spinal-anesthesia-after-intrathecal-injection-local-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/incidence-predictors-failed-spinal-anesthesia-after-intrathecal-injection-local-2023/"/>
<published>2026-10-27T22:35:32.011Z</published>
<updated>2026-10-27T22:35:32.011Z</updated>
<summary>Cohort study · Anesth Analg, 2023. Failed spinal anesthesia requiring an alternative anesthetic: Failed spinal anesthesia requiring an alternative anesthetic 2.1%</summary>
</entry>
<entry>
<title>Maternal Cardiovascular Morbidity Events Following Preeclampsia: A Retrospective Cohort Study</title>
<id>https://currentanesthesia.com/studies/maternal-cardiovascular-morbidity-events-following-preeclampsia-a-retrospective-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/maternal-cardiovascular-morbidity-events-following-preeclampsia-a-retrospective-2022/"/>
<published>2026-10-27T22:35:32.011Z</published>
<updated>2026-10-27T22:35:32.011Z</updated>
<summary>Cohort study · Anesth Analg, 2022. Composite of maternal cardiovascular morbidity events, during delivery hospital admission — Preeclampsia without severe features vs Without preeclampsia: aOR 1.87 (95% CI 1.78-1.97)</summary>
</entry>
<entry>
<title>Ondansetron for the Prevention of Pruritus in Women Undergoing Cesarean Delivery With Intrathecal Opioid: A Systematic Review and Meta-Analysis</title>
<id>https://currentanesthesia.com/studies/ondansetron-for-the-prevention-of-pruritus-in-women-undergoing-cesarean-delivery-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/ondansetron-for-the-prevention-of-pruritus-in-women-undergoing-cesarean-delivery-2023/"/>
<published>2026-10-27T22:35:32.011Z</published>
<updated>2026-10-27T22:35:32.011Z</updated>
<summary>Meta-analysis · Anesth Analg, 2023. Presence of pruritus — Ondansetron vs Placebo: RR 0.81 (95% CI 0.71-0.92); I 2 = 64%</summary>
</entry>
<entry>
<title>Outpatient Treatment With Gabapentin in Women With Severe Acute Pain After Cesarean Delivery Is Ineffective: A Randomized, Double-Blind, Placebo-Controlled Trial</title>
<id>https://currentanesthesia.com/studies/outpatient-treatment-with-gabapentin-in-women-with-severe-acute-pain-after-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/outpatient-treatment-with-gabapentin-in-women-with-severe-acute-pain-after-2023/"/>
<published>2026-10-27T22:35:32.011Z</published>
<updated>2026-10-27T22:35:32.011Z</updated>
<summary>Randomized controlled trial · Anesth Analg, 2023. Time to opioid cessation: Gabapentin median 2 (25th-75th percentiles 1-3) weeks · Placebo median 2 (25th-75th percentiles 1-3) weeks</summary>
</entry>
</feed>
